ArticleThe Journal of dermatological treatment2020
Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears.
Article in The Journal of dermatological treatment, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.
- Cutaneous manifestations and considerations in COVID-19 pandemic: A systematic review.Dermatologic therapy · 2020Pooled it
- Biologic Therapies Decrease Disease Severity and Improve Depression and Anxiety Symptoms in Psoriasis Patients.Life (Basel, Switzerland) · 2023Article
- The Relationship Between Psoriasis, COVID-19 Infection and Vaccination During Treatment of Patients.Advances in experimental medicine and biology · 2023Article
- Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis.Psoriasis (Auckland, N.Z.) · 2023Review
- COVID-19 Knowledge in Patients with Psoriasis Receiving Systemic Therapy: a Questionnaire Study.Dermatology practical & conceptual · 2022Article
- Letter to the editor regarding the article "Oguz Topal I, Kara Polat A, Zindancı İ, et al. Adherence to systemic therapy in patients with psoriasis during the COVID-19 pandemic: A multicenter study. J Cosmet Dermatol. 2021;10.1111/jocd.14610."Journal of cosmetic dermatology · 2022Article
- SARS-CoV-2 serology in patients on biological therapy or apremilast for psoriasis: a study of 93 patients in the Italian red zone.Journal of the European Academy of Dermatology and Venereology : JEADV · 2022Article
- Acute exacerbation of psoriasis after COVID-19 Pfizer vaccination.Proceedings (Baylor University. Medical Center) · 2022Article
- The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review.Clinical, cosmetic and investigational dermatology · 2022Review
- Real world practice indirect comparison between guselkumab and risankizumab: Results from an Italian retrospective study.Dermatologic therapy · 2022Article
- Reply to "Psoriasis exacerbation after COVID-19 vaccination: report of 14 cases from a single centre" by Sotiriou E et al.Journal of the European Academy of Dermatology and Venereology : JEADV · 2022Article
- Incidence of COVID-19 in a cohort of dermatology patients receiving immunomodulating biologic medications.International journal of dermatology · 2021Article
- The overall impact of COVID-19 on healthcare during the pandemic: A multidisciplinary point of view.Health science reports · 2021Review
- COVID-19 in Patients with Atopic Dermatitis Treated with Dupilumab: Three Cases and a Literature Review.Clinical, cosmetic and investigational dermatology · 2021Article
- The impact of COVID-19 in patients with psoriasis: A multicenter study in Istanbul.Dermatologic therapy · 2021Article
- Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy.Journal of the European Academy of Dermatology and Venereology : JEADV · 2020Article
- COVID-19 and immunosuppressive therapy in dermatology.Dermatologic therapy · 2020Review
- Comment on "Psoriasis, COVID-19, and acute respiratory distress syndrome: Focusing on the risk of concomitant biological treatment".Dermatologic therapy · 2020Article
- Psoriasis and COVID-19: A narrative review with treatment considerations.Dermatologic therapy · 2020Review
- SARS-CoV-2 asymptomatic infection in a patient under treatment with dupilumab.Journal of the European Academy of Dermatology and Venereology : JEADV · 2020Article
Corrections and comments
- Commented on by
- Comment on
- Comment on
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.